Skip to main content
. 2016 Sep 22;5(10):84. doi: 10.3390/jcm5100084

Figure 1.

Figure 1

Immune checkpoints receptors and ligands on T cell, dendritic cell and tumour cell surfaces. T cell inhibitory signalling demonstrated with red arrows, stimulatory signalling demonstrated with green arrows. Site of action for developed Anti-PD-1, Anit-PD-L1 and Anti-CTLA-4 antibodies shown with black arrows.